Systematic review and stratified meta-analysis of the efficacy of carnosine in animal models of ischemic stroke

Journal of Cerebral Blood Flow and Metabolism

Volumn 36, Issue 10, 2016, Pages 1686-1694

  Davis, Charles K ^a   Laud, Peter J ^b   Bahor, Zsanett ^c   Rajanikant, G K ^a   Majid, Arshad ^d  

^a NATIONAL INSTITUTE OF TECHNOLOGY CALICUT   (India)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

^d UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

Carnosine; ischemic stroke; meta analysis; neuroprotection; systematic review

Indexed keywords

CARNOSINE; NEUROPROTECTIVE AGENT;

ANIMAL MODEL; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CONFIDENCE INTERVAL; DOSE RESPONSE; DRUG EFFICACY; MEDLINE; NEUROLOGIC DISEASE; NONHUMAN; PRIORITY JOURNAL; PUBLICATION; REVIEW; SCORING SYSTEM; SYSTEMATIC REVIEW; TREATMENT OUTCOME; WEB OF SCIENCE; ANIMAL; COMPLICATION; DISEASE MODEL; META ANALYSIS; STROKE; TIME TO TREATMENT;

ANIMALS; BRAIN ISCHEMIA; CARNOSINE; DISEASE MODELS, ANIMAL; NEUROPROTECTIVE AGENTS; STROKE; TIME-TO-TREATMENT; TREATMENT OUTCOME;

EID: 84989866723     PISSN: 0271678X     EISSN: 15597016     Source Type: Journal    
DOI: 10.1177/0271678X16658302     Document Type: Review

References (22)

1. del Zoppo GJ, Saver JL, Jauch EC, et al. Expansion of the time window for treatment of acute ischemic stroke with intravenous tissue plasminogen activator: a science advisory from the American Heart Association/American Stroke Association. Stroke 2009; 40: 2945-2948
2. Majid A. Neuroprotection in stroke: past, present, and future. ISRN Neurol 2014; 2014: 1-17
3. De Keyser J, Sulter G, and Luiten PG. Clinical trials with neuroprotective drugs in acute ischaemic stroke: are we doing the right thing? Trends Neurosci 1999; 22: 535-540
4. Mergenthaler P, and Meisel A. Do stroke models model stroke? Dis Model Mech 2012; 5: 718-725
5. Bellia F, Vecchio G, Cuzzocrea S, et al. Neuroprotective features of carnosine in oxidative driven diseases. Mol Aspect Med 2011; 32: 258-266
6. Hipkiss AR. Carnosine, and its possible roles in nutrition, and health. Adv Food Nutr Res 2009; 57: 87-154
7. Baek SH, Noh AR, Kim KA, et al. Modulation of mitochondrial function, and autophagy mediates carnosine neuroprotection against ischemic brain damage. Stroke 2014; 45: 2438-2443
8. Bae ON, Serfozo K, Baek SH, et al. Safety, and efficacy evaluation of carnosine, an endogenous neuroprotective agent for ischemic stroke. Stroke 2013; 44: 205-212
9. Rajanikant GK, Zemke D, Senut MC, et al. Carnosine is neuroprotective against permanent focal cerebral ischemia in mice. Stroke 2007; 38: 3023-3031
10. Min J, Senut MC, Rajanikant K, et al. Differential neuroprotective effects of carnosine, anserine, and N -acetyl carnosine against permanent focal ischemia. J Neurosci Res 2008; 86: 2984-2991
11. Bae ON, and Majid A. Role of histidine/histamine in carnosine-induced neuroprotection during ischemic brain damage. Brain Res 2013; 1527: 246-254
12. Pekcetin C, Kiray M, Ergur B, et al. Carnosine attenuates oxidative stress, and apoptosis in transient cerebral ischemia in rats. Acta Biol Hung 2009; 60: 137-148
13. Macleod MR, O'Collins T, Howells DW, and Donnan GA. Pooling of animal experimental data reveals influence of study design, and publication bias. Stroke 2004; 35: 1203-1208
14. Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews, and meta-analyses of studies that evaluate health care interventions: explanation, and elaboration. Ann Int Med 2009; 151: W65-94
15. Vesterinen HM, Currie GL, Carter S, et al. Systematic review, and stratified meta-analysis of the efficacy of RhoA, and Rho kinase inhibitors in animal models of ischaemic stroke. Syst Rev 2013; 2: 33
16. Shen Y, He P, Fan YY, et al. Carnosine protects against permanent cerebral ischemia in histidine decarboxylase knockout mice by reducing glutamate excitotoxicity. Free Radic Biol Med 2010; 48: 727-735
17. Park HS, Han KH, Shin JA, et al. The neuroprotective effects of carnosine in early stage of focal ischemia rodent model. J Korean Neurosurg Soc 2014; 55: 125
18. Wang JP, Yang ZT, Liu C, et al. L-carnosine inhibits neuronal cell apoptosis through signal transducer, and activator of transcription 3 signaling pathway after acute focal cerebral ischemia. Brain Res 2013; 1507: 125-133
19. Anderson NE, Broad JB, and Bonita R. Delays in hospital admission, and investigation in acute stroke. BMJ 1995; 311: 162
20. de Courten B, Jakubova M, de Courten MP, et al. Effects of carnosine supplementation on glucose metabolism: pilot clinical trial. Obesity 2016; 24: 1027-1034
21. Lombardi C, Carubelli V, Lazzarini V, et al. Effects of oral administration of orodispersible levo-carnosine on quality of life, and exercise performance in patients with chronic heart failure. Nutrition 2015; 31: 72-78
22. Fisher M, Feuerstein G, Howells DW, et al. Update of the stroke therapy academic industry roundtable preclinical recommendations. Stroke 2009; 40: 2244-2250